Market by Product, Technology, Application, Industry Vertical, and Regional Outlook | Forecast 2021-2028
The detailed analysis of the global DNA sequencing market shows that in terms of revenue, the industry is estimated to grow at a CAGR of 17.21% during the forecasting years 2021-2028. The market was valued at $9217 million in 2020, and is expected to generate a revenue of $35684.5 million by 2028.
Report scope can be customized per your requirements. Request For Customization
The process of
asserting the nucleic acid sequence is termed DNA sequencing. The market for DNA
sequencing has led to a paradigm shift in the genomics sectors and molecular
biology. The information of DNA sequences of genes and supplementary parts of
the organism’s genome has expanded prominence in researches of Life sciences as
well as in applied fields, such as cancer diagnostics, forensics, and others.
The cost of genome
sequencing has been decreasing dramatically, by nearly a million-fold in the
last five to six years. Personalized medicines open avenues for the growth of
the DNA sequencing market, as DNA sequencing techniques are used to develop
personalized medicines. Within the healthcare sector, several medicinal
organizations use DNA sequencing techniques for personalized medicines,
especially in the field of cancer therapy and cardiovascular disease
treatments. Emerging and applied markets in DNA sequencing are another major
driver of the DNA sequencing market’s growth. Single-Molecule Real-Time
Sequencing (SMRT), is an emerging technology in DNA sequencing, which is a
third-generation sequencing developed by Pacific Biosciences.
The study aims to get
an overview of the DNA sequencing market in terms of various factors. Within
this report, the key insights and the market summary regarding the DNA sequencing
industry have been discussed. Also, the impact of COVID-19 on the DNA sequencing
market, industry components, key impact analysis, vendor scorecard, market
attractiveness matrix, and key market strategies have been studied in detail.
Market drivers like the prevalence of cancer cases, advancements in technology, and applications of DNA sequencing for animal & plant reproduction are driving the DNA sequencing market growth. However, challenges associated with DNA sequencing technologies in bioinformatics, lack of skilled professionals in emerging economies, and limitations of DNA sequencing technology in diagnostic testing, which are obstructing the industry growth. Key opportunities like extensive research & development in DNA Sequencing and growth in genome mapping programs can be leveraged by the industry to reach the projected growth.
Geographies
covered in the global DNA sequencing market by region are:
• North America: Canada and the United
States
• Asia-Pacific: Australia & New
Zealand, Japan, India, South Korea, China, ASEAN countries, and Rest of
Asia-Pacific
• Europe: Russia, Spain, the United
Kingdom, Germany, France, Italy, and Rest of Europe
• Latin America: Mexico, Brazil, and
Rest of Latin America
• Middle East and Africa: The United
Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of Middle East
& Africa
The
market for DNA sequencing has been segmented as follows:
• By Product
o Instruments & Consumables
• Instruments & Consumables Type
o Consumables
o Instruments
• Instruments & Consumables
Platform
o NGS (Next Generation Sequencing)
• RNA Sequencing
• Targeted Resequencing
• Whole-exome Sequencing
• Whole-genome Sequencing
• Chip Sequencing
• De novo Sequencing
• Methyl Sequencing
o Sanger
o Sequencing Services
o Bioinformatics
• By Technology
o Sequencing by Ligation (SBL)
o Sequencing by Synthesis
o Ion Semiconductor Sequencing
o Chain Termination Sequencing
o Pyrosequencing
o Single-molecule Real-time Sequencing
(SMRT)
o Nanopore Sequencing
o Other Technologies
• By Application
o Biomarker Discovery
o Diagnostics
o Reproductive Health
o Personalized Medicine
o Drug Discovery
o Agriculture & Animal Research
o Forensics
o Other Applications
• By Industry Verticals
o Research Centers And Academic &
Government Institutes
o Pharmaceutical
o Biotechnology Companies
o Hospitals & Clinics
o Other Industry Verticals
The top players engaged
in the DNA sequencing market are BGI Genomics, Danaher Corporation (Integrated
DNA Technologies Inc), Thermo Fisher Scientific Inc, Merck KgaA, Agilent
Technologies Inc, Spiral Genetics Inc, Eurofins Scientific, F Hoffmann-La
Roche, Illumina Inc, Siemens Healthineers AG, Adaptive Biotechnologies Inc,
Bio-Rad Laboratories Inc, Asuragen Inc, Perkinelmer Inc, and Pacific
Biosciences of California Inc. The strategic analysis for each of these companies
has been covered in detail. The DNA Sequencing market by company profile helps
to dive into the data about the key market players in this industry.
1. GLOBAL
DNA SEQUENCING MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE DNA SEQUENCING MARKET
2.2. KEY
INSIGHTS
2.2.1. APPLICATIONS
OF LIQUID BIOPSY
2.2.2. EMERGING
DEVELOPING ECONOMIES
2.2.3. DEVELOPMENT
IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY
2.2.4. NEXT
GENERATION SEQUENCING
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. INDUSTRY
COMPONENTS
2.5. KEY
IMPACT ANALYSIS
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. PREVALENCE
OF CANCER CASES
2.9.2. ADVANCEMENTS
IN TECHNOLOGY
2.9.3. APPLICATIONS
OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION
2.10. MARKET
RESTRAINTS
2.10.1. CHALLENGES
ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS
2.10.2. LACK
OF SKILLED PROFESSIONALS IN EMERGING ECONOMIES
2.10.3. LIMITATIONS
OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING
2.11. MARKET
OPPORTUNITIES
2.11.1. EXTENSIVE
RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
2.11.2. GROWTH
IN GENOME MAPPING PROGRAMS
3. GLOBAL
DNA SEQUENCING MARKET – BY PRODUCT
3.1. INSTRUMENTS
& CONSUMABLES
3.1.1. INSTRUMENTS
& CONSUMABLES TYPE
3.1.1.1. CONSUMABLES
3.1.1.2. INSTRUMENTS
3.1.2. INSTRUMENTS
& CONSUMABLES PLATFORM
3.1.2.1. NGS
(NEXT GENERATION SEQUENCING)
3.1.2.1.1. RNA
SEQUENCING
3.1.2.1.2. TARGETED
RESEQUENCING
3.1.2.1.3. WHOLE-EXOME
SEQUENCING
3.1.2.1.4. WHOLE-GENOME
SEQUENCING
3.1.2.1.5. CHIP
SEQUENCING
3.1.2.1.6. DE
NOVO SEQUENCING
3.1.2.1.7. METHYL
SEQUENCING
3.1.2.2. SANGER
3.2. SEQUENCING
SERVICES
3.3. BIOINFORMATICS
4. GLOBAL
DNA SEQUENCING MARKET – BY TECHNOLOGY
4.1. SEQUENCING
BY SYNTHESIS
4.2. ION
SEMICONDUCTOR SEQUENCING
4.3. CHAIN
TERMINATION SEQUENCING
4.4. PYROSEQUENCING
4.5. SEQUENCING
BY LIGATION (SBL)
4.6. SINGLE-MOLECULE
REAL-TIME SEQUENCING (SMRT)
4.7. NANOPORE
SEQUENCING
4.8. OTHER
TECHNOLOGIES
5. GLOBAL
DNA SEQUENCING MARKET – BY APPLICATION
5.1. BIOMARKER
DISCOVERY
5.2. DIAGNOSTICS
5.3. REPRODUCTIVE
HEALTH
5.4. PERSONALIZED
MEDICINE
5.5. DRUG
DISCOVERY
5.6. AGRICULTURE
& ANIMAL RESEARCH
5.7. FORENSICS
5.8. OTHER
APPLICATIONS
6. GLOBAL
DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH
CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
6.2. PHARMACEUTICAL
6.3. BIOTECHNOLOGY
COMPANIES
6.4. HOSPITALS
& CLINICS
6.5. OTHER
INDUSTRY VERTICALS
7. GLOBAL
DNA SEQUENCING MARKET – REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY PRODUCT
7.1.1.1. INSTRUMENTS
& CONSUMABLES MARKET BY TYPE
7.1.1.2. INSTRUMENTS
& CONSUMABLES MARKET BY PLATFORM
7.1.1.2.1. NGS
MARKET BY TYPE
7.1.2. MARKET
BY TECHNOLOGY
7.1.3. MARKET
BY APPLICATION
7.1.4. MARKET
BY INDUSTRY VERTICALS
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. THE
UNITED STATES
7.1.5.2. CANADA
7.2. EUROPE
7.2.1. MARKET
BY PRODUCT
7.2.1.1. INSTRUMENTS
& CONSUMABLES MARKET BY TYPE
7.2.1.2. INSTRUMENTS
& CONSUMABLES MARKET BY PLATFORM
7.2.1.2.1. NGS
MARKET BY TYPE
7.2.2. MARKET
BY TECHNOLOGY
7.2.3. MARKET
BY APPLICATION
7.2.4. MARKET
BY INDUSTRY VERTICALS
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. GERMANY
7.2.5.2. FRANCE
7.2.5.3. THE
UNITED KINGDOM
7.2.5.4. ITALY
7.2.5.5. RUSSIA
7.2.5.6. SPAIN
7.2.5.7. REST
OF EUROPE
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY PRODUCT
7.3.1.1. INSTRUMENTS
& CONSUMABLES MARKET BY TYPE
7.3.1.2. INSTRUMENTS
& CONSUMABLES MARKET BY PLATFORM
7.3.1.2.1. NGS
MARKET BY TYPE
7.3.2. MARKET
BY TECHNOLOGY
7.3.3. MARKET
BY APPLICATION
7.3.4. MARKET
BY INDUSTRY VERTICALS
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.2. JAPAN
7.3.5.3. INDIA
7.3.5.4. AUSTRALIA
& NEW ZEALAND
7.3.5.5. SOUTH
KOREA
7.3.5.6. ASEAN
COUNTRIES
7.3.5.7. REST
OF ASIA-PACIFIC
7.4. LATIN
AMERICA
7.4.1. MARKET
BY PRODUCT
7.4.1.1. INSTRUMENTS
& CONSUMABLES MARKET BY TYPE
7.4.1.2. INSTRUMENTS
& CONSUMABLES MARKET BY PLATFORM
7.4.1.2.1. NGS
MARKET BY TYPE
7.4.2. MARKET
BY TECHNOLOGY
7.4.3. MARKET
BY APPLICATION
7.4.4. MARKET
BY INDUSTRY VERTICALS
7.4.5. COUNTRY
ANALYSIS
7.4.5.2. BRAZIL
7.4.5.3. REST
OF LATIN AMERICA
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY PRODUCT
7.5.1.1. INSTRUMENTS
& CONSUMABLES MARKET BY TYPE
7.5.1.2. INSTRUMENTS
& CONSUMABLES MARKET BY PLATFORM
7.5.1.2.1. NGS
MARKET BY TYPE
7.5.2. MARKET
BY TECHNOLOGY
7.5.3. MARKET
BY APPLICATION
7.5.4. MARKET
BY INDUSTRY VERTICALS
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. SAUDI
ARABIA
7.5.5.2. UNITED
ARAB EMIRATES
7.5.5.3. TURKEY
7.5.5.4. SOUTH
AFRICA
7.5.5.5. REST
OF MIDDLE EAST & AFRICA
8. COMPETITIVE
LANDSCAPE
8.1. ADAPTIVE
BIOTECHNOLOGIES INC
8.2. AGILENT
TECHNOLOGIES INC
8.3. ASURAGEN
INC
8.4. BGI
GENOMICS
8.5. BIO-RAD
LABORATORIES INC
8.6. DANAHER
CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
8.7. EUROFINS
SCIENTIFIC
8.8. F
HOFFMANN-LA ROCHE
8.9. ILLUMINA
INC
8.10. MERCK
KGAA
8.11. PACIFIC
BIOSCIENCES OF CALIFORNIA INC
8.12. PERKINELMER
INC
8.13. SIEMENS
HEALTHINEERS AG
8.14. SPIRAL
GENETICS INC
8.15. THERMO
FISHER SCIENTIFIC INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL DNA SEQUENCING MARKET, REGIONAL
OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS, ANNOUNCEMENTS &
DIVESTITURES
TABLE 5: ACQUISITIONS & MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
TABLE 7: GLOBAL DNA SEQUENCING MARKET, BY PRODUCT,
2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL INSTRUMENTS & CONSUMABLES
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL INSTRUMENTS & CONSUMABLES
MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL NGS MARKET, BY TYPE, 2021-2028 (IN $
MILLION)
TABLE 11: GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY,
2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL DNA SEQUENCING MARKET, BY INDUSTRY
VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL DNA SEQUENCING MARKET, BY REGION,
2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA DNA SEQUENCING MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA DNA SEQUENCING MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA INSTRUMENTS & CONSUMABLES
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA INSTRUMENTS & CONSUMABLES
MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA NGS MARKET, BY TYPE,
2021-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA DNA SEQUENCING MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 22: NORTH AMERICA DNA SEQUENCING MARKET, BY
INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 23: EUROPE DNA SEQUENCING MARKET, COUNTRY OUTLOOK,
2021-2028 (IN $ MILLION)
TABLE 24: EUROPE DNA SEQUENCING MARKET, BY PRODUCT,
2021-2028 (IN $ MILLION)
TABLE 25: EUROPE INSTRUMENTS & CONSUMABLES
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 26: EUROPE INSTRUMENTS & CONSUMABLES
MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 27: EUROPE NGS MARKET, BY TYPE, 2021-2028 (IN $
MILLION)
TABLE 28: EUROPE DNA SEQUENCING MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 29: EUROPE DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 30: EUROPE DNA SEQUENCING MARKET, BY INDUSTRY
VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC DNA SEQUENCING MARKET, COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC DNA SEQUENCING MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC INSTRUMENTS & CONSUMABLES
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 34: ASIA-PACIFIC INSTRUMENTS & CONSUMABLES
MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 35: ASIA-PACIFIC NGS MARKET, BY TYPE, 2021-2028
(IN $ MILLION)
TABLE 36: ASIA-PACIFIC DNA SEQUENCING MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 37: ASIA-PACIFIC DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 38: ASIA-PACIFIC DNA SEQUENCING MARKET, BY
INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 39: LATIN AMERICA DNA SEQUENCING MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 40: LATIN AMERICA DNA SEQUENCING MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 41: LATIN AMERICA INSTRUMENTS & CONSUMABLES
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 42: LATIN AMERICA INSTRUMENTS & CONSUMABLES
MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 43: LATIN AMERICA NGS MARKET, BY TYPE,
2021-2028 (IN $ MILLION)
TABLE 44: LATIN AMERICA DNA SEQUENCING MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 45: LATIN AMERICA DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 46: LATIN AMERICA DNA SEQUENCING MARKET, BY
INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 47: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 48: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 49: MIDDLE EAST AND AFRICA INSTRUMENTS &
CONSUMABLES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 50: MIDDLE EAST AND AFRICA INSTRUMENTS &
CONSUMABLES MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 51: MIDDLE EAST AND AFRICA NGS MARKET, BY TYPE,
2021-2028 (IN $ MILLION)
TABLE 52: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 53: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 54: MIDDLE EAST AND AFRICA DNA SEQUENCING
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 1: GLOBAL DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 2: LIMITATIONS OF DNA
SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3: GLOBAL DNA SEQUENCING
MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 4: GLOBAL DNA SEQUENCING
MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL INSTRUMENTS
& CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL INSTRUMENTS
& CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL INSTRUMENTS
& CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL NGS MARKET, BY
RNA SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL NGS MARKET, BY
TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL NGS MARKET, BY
WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL NGS MARKET, BY
WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL NGS MARKET, BY
CHIP SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL NGS MARKET, BY DE
NOVO SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL NGS MARKET, BY
METHYL SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL INSTRUMENTS &
CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL DNA SEQUENCING
MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL DNA SEQUENCING
MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL DNA SEQUENCING
MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 19: GLOBAL DNA SEQUENCING
MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL DNA SEQUENCING
MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL DNA SEQUENCING
MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL DNA SEQUENCING
MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL DNA SEQUENCING
MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)
FIGURE 24: GLOBAL DNA SEQUENCING
MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028 (IN $
MILLION)
FIGURE 25: GLOBAL DNA SEQUENCING
MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 26: GLOBAL DNA SEQUENCING
MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 27: GLOBAL DNA SEQUENCING
MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 28: GLOBAL DNA SEQUENCING
MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 29: GLOBAL DNA SEQUENCING
MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 30: GLOBAL DNA SEQUENCING
MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 31: GLOBAL DNA SEQUENCING MARKET,
BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32: GLOBAL DNA SEQUENCING
MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 33: GLOBAL DNA SEQUENCING
MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 34: GLOBAL DNA SEQUENCING
MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 35: GLOBAL DNA SEQUENCING
MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 36: GLOBAL DNA SEQUENCING
MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 37: GLOBAL DNA SEQUENCING
MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2028
(IN $ MILLION)
FIGURE 38: GLOBAL DNA SEQUENCING
MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)
FIGURE 39: GLOBAL DNA SEQUENCING
MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 40: GLOBAL DNA SEQUENCING
MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 41: GLOBAL DNA SEQUENCING
MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 42: THE UNITED STATES DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: CANADA DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 44: GERMANY DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 45: FRANCE DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 46: THE UNITED KINGDOM DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: ITALY DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 48: RUSSIA DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 49: SPAIN DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 50: REST OF EUROPE DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 51: CHINA DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 52: JAPAN DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 53: INDIA DNA SEQUENCING MARKET
2021-2028 (IN $ MILLION)
FIGURE 54: AUSTRALIA & NEW
ZEALAND DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 55: SOUTH KOREA DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 56: ASEAN COUNTRIES DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 57: REST OF ASIA-PACIFIC DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 58: MEXICO DNA SEQUENCING
MARKET 2021-2028 ($ MILLION)
FIGURE 59: BRAZIL DNA SEQUENCING
MARKET 2021-2028 ($ MILLION)
FIGURE 60: REST OF LATIN AMERICA
DNA SEQUENCING MARKET 2021-2028 ($ MILLION)
FIGURE 61: SAUDI ARABIA DNA
SEQUENCING MARKET 2021-2028 ($ MILLION)
FIGURE 62: UNITED ARAB EMIRATES DNA
SEQUENCING MARKET 2021-2028 ($ MILLION)
FIGURE 63: TURKEY DNA SEQUENCING
MARKET 2021-2028 ($ MILLION)
FIGURE 64: SOUTH AFRICA DNA
SEQUENCING MARKET 2021-2028 ($ MILLION)
FIGURE 65: REST OF MIDDLE EAST
& AFRICA DNA SEQUENCING MARKET 2021-2028 ($ MILLION)